Detalhe da pesquisa
1.
A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus: A study protocol.
Diabetes Obes Metab
; 25(3): 649-655, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309971
2.
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial.
Diabetes Obes Metab
; 25(12): 3671-3681, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661308
3.
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy.
Diabetes Obes Metab
; 25(12): 3788-3797, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37724698
4.
Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.
Diabetes Obes Metab
; 25(3): 785-795, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433709
5.
Chinese clinical guidelines for continuous glucose monitoring (2018 edition).
Diabetes Metab Res Rev
; 35(6): e3152, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30884108
6.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, and Dose-Increasing Study on the Safety, Tolerability and PK/PD of Multiple Doses of HSK7653 by Oral Administration in Patients with Type 2 Diabetes Mellitus in China.
Diabetes Ther
; 15(1): 183-199, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37930584
7.
Clinical and genetic characteristics of CEL-MODY (MODY8): a literature review and screening in Chinese individuals diagnosed with early-onset type 2 diabetes.
Endocrine
; 83(1): 99-109, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726640
8.
Personalized glucose-lowering effect of chiglitazar in type 2 diabetes.
iScience
; 26(11): 108195, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942014
9.
Tirzepatide versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial.
Nat Med
; 29(6): 1500-1510, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231074
10.
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross-sectional study.
J Diabetes
; 15(9): 765-776, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310028
11.
A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology.
Diabetes
; 72(6): 812-818, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36939643
12.
Prevalence and Clinical Characteristics of PDX1 Variant Induced Diabetes in Chinese Early-Onset Type 2 Diabetes.
J Clin Endocrinol Metab
; 108(12): e1686-e1694, 2023 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279936
13.
The Association between Non-Alcoholic Fatty Liver Disease (NAFLD) and Advanced Fibrosis with Serological Vitamin B12 Markers: Results from the NHANES 1999-2004.
Nutrients
; 14(6)2022 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35334881
14.
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial.
EClinicalMedicine
; 54: 101691, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36247927
15.
Sex differences in the prevalence of obesity in 800,000 Chinese adults with type 2 diabetes.
Endocr Connect
; 10(2): 139-145, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33543732
16.
Silent hemoglobin variant during capillary electrophoresis: A case report.
J Diabetes Investig
; 11(4): 1014-1017, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32020779
17.
Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis.
Bone
; 130: 115121, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31678488
18.
Insulin delivery with a needle-free insulin injector versus a conventional insulin pen in Chinese patients with type 2 diabetes mellitus: A 16-week, multicenter, randomized clinical trial (the FREE study).
EClinicalMedicine
; 23: 100368, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32529176
19.
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT).
J Diabetes
; 12(9): 668-676, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329194
20.
[Features of insulin secretion and insulin resistance in newly diagnosed type 2 diabetes of different body mass indices].
Zhonghua Yi Xue Za Zhi
; 89(16): 1117-21, 2009 Apr 28.
Artigo
em Zh
| MEDLINE | ID: mdl-19595144